Release of Extracellular DNA during Biofilm Formation in Staphylococcus aureus

金黄色葡萄球菌生物膜形成过程中细胞外 DNA 的释放

• 批准号: 9905483
• 负责人: Daniel Kahne
• 金额: $ 63.02万
• 依托单位: HARVARD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-05-11 至 2023-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9905483
• 关键词: Anabolism; Antibiotic Resistance; Antibiotics; Bacteria; Biogenesis; Biological Assay; Biosensor; Catheters; Cell Wall; Cells; Cellular Structures; Communities; Congo Red; Cytolysis; Cytoplasmic Protein; DNA; Devices; Drops; Drug Targeting; Dyes; Electrostatics; Enzymes; Extracellular Matrix; Genes; Genetic Transcription; Genus staphylococcus; Glucose; Goals; Growth; Impairment; Individual; Infection; Label; Measures; Mediating; Microbial Biofilms; Modeling; Molecular Genetics; Mucous Membrane; Mutation; Nosocomial Infections; Nucleotides; Pathway interactions; Peptidoglycan; Periodicity; Pharmaceutical Preparations; Polymers; Polysaccharides; Proteins; Resistance; Role; Second Messenger Systems; Skin; Source; Staphylococcus aureus; Surface; Teichoic Acids; Vancomycin-resistant S. aureus; Work; adenine phosphoribosyltransferase; base; cell envelope; chronic wound; combat; drug development; drug discovery; experimental study; extracellular; gene function; genetic approach; genome-wide; implantable device; implantation; lipoteichoic acid; macromolecule; methicillin resistant Staphylococcus aureus; mutant; new therapeutic target; pathogenic bacteria; phosphoric diester hydrolase; small molecule; tool; transposon sequencing

Staphylococcus aureus is often the cause of nosocomial infections, particularly when these infections involve bacterial colonization of indwelling devices. The fact that these bacteria are frequently carried asymptomatically on the skin and mucosal surfaces of many individuals permits easy colonization of the pristine surfaces of such devices during implantation. Once biofilms grow on these surfaces, they are difficult to eradicate because the constituent cells become largely insensitive to the action of many commonly used antibiotics. These findings, combined with the fact that a large percentage of S. aureus isolates identified in infections are now resistant to numerous antibiotics makes it clear that new ways of combating staphylococcal biofilm-associated infections need to be developed. The goal of this project is to understand how methicillin-resistant S. aureus (MRSA) forms biofilms and thereby identify targets for the discovery of drugs that block or reverse the formation of surface-associated communities. To form a biofilm, S. aureus must produce an extracellular matrix. Major components of the matrix are proteins and DNA. Many of the proteins are cytoplasmic in origin and are thus moonlighting in their second role as components of the matrix. The extracellular DNA requires the matrix proteins in order to adhere to the cells, serving as an electrostatic net that holds the remaining cells together in the biofilm. Using a comprehensive molecular genetic approach, we identified genes needed for the release of extracellular DNA during biofilm formation, including the gene for a phosphodiesterase that controls the levels of a well-known second messenger, cyclic-di-AMP. We have shown that cyclic-di-AMP levels drop when cells enter the biofilm state. We propose to take advantage of a biosensor for measuring cyclic-di-AMP levels in cells to identify genes that control its levels as cells enter the biofilm state. We will take advantage of the discovery that mutants with altered levels of the second messenger are resistant to the dye Congo red to discover additional genes involved in controlling cyclic-di-AMP levels. We propose that the drop in cyclic-di-AMP levels weakens the cell envelope, causing some cells to lyse and liberate protein and DNA for incorporation into the matrix. We will investigate the hypothesis that low cyclic-di-AMP levels impair proper biosynthesis of teichoic acid, the cell envelope polymers needed for cell wall integrity. Finally, we exploit our fluorescent assay for c-di-AMP to carry out a cell-based screen for small molecules that cause levels of the second messenger to rise. These hits will be a starting point for the development of drugs that block biofilm formation.

金黄色葡萄球菌通常是医院感染的原因，特别是当 这些感染涉及细菌在留置装置上的定植。这些细菌 经常无症状地携带在许多个体的皮肤和粘膜表面上 允许在植入过程中容易地在这种装置的原始表面上定植。一旦 生物膜生长在这些表面上，它们难以根除，因为组成细胞 对许多常用抗生素的作用变得很不敏感。这些发现， 再加上S.在感染中鉴定的金黄色葡萄球菌分离株是 现在对许多抗生素都有抗药性，这表明对抗葡萄球菌的新方法 需要开发生物膜相关的感染。这个项目的目标是了解 耐甲氧西林S.金黄色葡萄球菌（MRSA）形成生物膜，从而确定目标的 发现阻断或逆转表面相关群落形成的药物。 为了形成生物膜，S.金黄色葡萄球菌必须产生细胞外基质。的主要部件 基质是蛋白质和DNA。许多蛋白质起源于细胞质， 第二个角色是母体的组成部分。细胞外DNA需要 基质蛋白，以粘附到细胞上，作为一个静电网， 在生物膜中保留细胞。使用全面的分子遗传学方法，我们 确定了生物膜形成过程中释放细胞外DNA所需的基因，包括 磷酸二酯酶的基因控制着一种众所周知的第二信使的水平， 环二AMP。我们已经表明，当细胞进入生物膜状态时，cyclic-di-AMP水平下降。 我们建议利用生物传感器来测量细胞中的环二AMP水平 以确定当细胞进入生物膜状态时控制其水平的基因。我们将利用 发现第二信使水平改变的突变体对染料有抵抗力 刚果红发现参与控制环二磷酸腺苷水平的其他基因。 我们认为，环二磷酸腺苷水平的下降削弱了细胞的包膜， 一些细胞裂解并释放蛋白质和DNA以掺入基质中。我们将 研究低环-二-AMP水平损害磷壁酸的适当生物合成的假设， 酸，细胞壁完整性所需的细胞包膜聚合物。 最后，我们利用我们的c-di-AMP荧光检测进行了基于细胞的筛选， 导致第二信使水平上升的小分子。这些点击将是一个开始 这是开发阻止生物膜形成的药物的关键。